Compound effective as cerebral insufficiency improver
AssigneeSuntory Limited
InventorsToshio Tatsuoka, Kenji Suzuki, Fumio Satoh, Seiji Miyano, Kunihiro Sumoto
Life of this patent
Estimating the term…
Abstract
A compound having the formula (I): ##STR1## wherein A is --CH.sub.2 --, --O--, or --S--; R.sup.1 is CH.sub.3 or OCH.sub.3 ; R.sup.2 is hydroxy or carboxy which may be optionally esterized or amidated; R.sup.3 is H or a lower alkyl; and n is 0 or an integer of 1 to 6 or a pharmaceutically acceptable salt thereof.
Claims12
A compound having the formula (I):
- ##STR93## wherein A is --O--, or --S--;
- R.sup.1 is CH.sub.3 or OCH.sub.3 ;
- R.sup.2 is --COR.sup.4 wherein R.sup.4 is a morpholino group, thiomorpholino group, piperidino group or N-methyl piperazinyl group;
- R.sup.3 is H or a lower alkyl;
- and n is 0 or an integer of 1 to 6 and a salt thereof.
A pharmaceutical composition useful as an improver of cerebral insufficiency caused by cerebral ischemia comprising an effective amount of a compound of the formula (I) to improve a cerebral insufficiency caused by cerebral ischemia:
- ##STR97## wherein A is --O--, or --S--;
- R.sup.1 CH.sub.3 or OCH.sub.3 ;
- R.sup.2 is --COR.sup.4 wherein R.sup.4 is a morpholino group, thiomorpholino group, piperidino group or N-methyl piperazinyl group;
- R.sup.3 is H or a lower alkyl;
- and n is 0 or an integer of 1 to 6 and a pharmaceutically acceptable carrier therefor.
A method for improving cerebral insufficiency caused by cerebral ischemia, comprising administering an effective amount of a compound of the formula I to improve cerebral insuficiency caused by cerebral ischemia:
- ##STR101## wherein A is --O-- or --S--;
- R.sup.1 is CH.sub.3 or OCH.sub.3 ;
- R.sup.2 is --COR.sup.4 wherein R.sup.4 is a morpholino group, thiomorpholino group, piperidino group or N-methyl piperazinyl group;
- R.sup.3 is H or a lower alkyl;
- and n is 0 or an integer of 1 to 6 and a salt thereof, to a patient in need of such treatment.
Dependencies are inferred from the claim text.